Evidence map›Paper›PMID 23742795›Full record

ArticlePain2013

Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus.

Miroslav Misha Backonja, Nadine Attal, Ralf Baron, Didier Bouhassira, Mark Drangholt, Peter J Dyck, Robert R Edwards, Roy Freeman, Richard Gracely, Maija H Haanpaa and 17 more

Erratum issued 5 registry-linked trialsAbstract read
PubMed Publisher
In one paragraph

Article in Pain, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 5 registered trials, which are not on this map. Cited by 228 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
228citing papers in PubMed, 5 pooled it
22.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03692611 nacompletednot on this mapstarted 2019, after this paper: background citation

Evaluation of the Efficacy and Mechanisms of a Novel Intervention for Chronic Pain Tailored to People Living With HIV

TypeinterventionalSponsorUniversity of PittsburghRan2019 to 2025Enrolled278ConditionsChronic PainArmsSkills TO Manage Pain (STOMP), Comparison group
NCT03972332 completednot on this mapstarted 2018, after this paper: background citation

Pain Experience in Individuals With Chronic Low Back Pain: a Cohort Study

TypeobservationalSponsorUniversity of NottinghamRan2018 to 2020Enrolled97ConditionsLow Back PainArmsQuantitative Sensory Testing
NCT05864053 phase1 / phase2recruitingnot on this mapstarted 2024, after this paper: background citation

(2R,6R)-Hydroxynorketamine a Novel Therapeutic Analgesic for the Treatment of Neuropathic Pain: A Randomized Double Blind Cross-Over Trial.

TypeinterventionalSponsorRush University Medical CenterRan2024 to 2027Enrolled25ConditionsPain, NeuropathicArmsKetamine, (2R,6R)-hydroxynorketamine, Saline
NCT05906511 early_phase1recruitingnot on this mapstarted 2023, after this paper: background citation

Pharmacokinetics and Pharmacodynamics of Oral and Vaporized Delta-9-Tetrahydrocannabinol (THC) in Older Adults

TypeinterventionalSponsorYale UniversityRan2023 to 2026Enrolled20ConditionsPain, Tolerance, Oral vs Vaporized THC, Abuse LiabilityArmsDronabinol 5 MG, Dronabinol 10 MG, 2mg Purified THC in an ethanolic solution, 4mg Purified THC in an ethanolic solution, Placebo
NCT06030297 nacompletednot on this mapstarted 2023, after this paper: background citation

Diode Laser as a Biomarker for Neuropathic Pain of Peripheral Origin.

TypeinterventionalSponsorUniversity of UtahRan2023 to 2026Enrolled75ConditionsPeripheral NeuropathyArmsDiode Laser fiber type Selective Stimulator, ZTlido 1.8 % Topical System, PeriCam PSI NR, Medoc Quantitative Sensory Testing, Inactive Topical System
3 · Its place in the literature

Who cites it

228 citing papers in PubMed, 5 syntheses or guidelines pooled it, 553 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. OXTR rs53576 Variation with Breast and Nipple Pain in Breastfeeding Women.Pain management nursing : official journal of the American Society of Pain Management Nurses · 2021
    Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

168 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 20 institutions in 11 countries.

Miroslav Misha BackonjaDepartment of Neurology, University of Wisconsin-Madison, Madison, WI, USA CRI Lifetree Research, Salt Lake City, UT, USA INSERM U-987, Centre d'Evaluation et de Traitement de la Douleur, Hôpital Ambroise Paré, APHP, Boulogne-Billancourt, France Université Versailles Saint-Quentin, France Division of Neurological Pain Research and Therapy, Department of Neurology, Universitatsklinikum Schleswig-Holstein, Kiel, Germany Dental Public Health Sciences, University of Washington, Seattle, WA, USA Mayo Clinic, 200 First Street SW, Rochester, MN, USA Department of Anesthesiology, Harvard Medical School, Brigham & Women's Hospital, Chestnut Hill, MA, USA Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA Center for Neurosensory Disorders, University of North Carolina, CB No. 7280, 3330 Thurston Bldg, Chapel Hill, NC, USA Department of Neurosurgery, Helsinki University Central Hospital, Helsinki, Finland Clinical Pain Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, 17176 Stockholm, Sweden Clinic of Physical and Rehabilitation Medicine, Brugmann University Hospital, 4 place Van Gehuchten, B-1020 Brussels, Belgium Institute of Neuroscience, 52, Avenue E. Mounier, B-1200 Brussels, Belgium Université Catholique de Louvain, Leuven, Belgium Department of Neurology, Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil GmbH, Ruhr-University Bochum, Germany Danish Pain Research Center and Department of Neurology, Aarhus University Hospital, Aarhus, Denmark Department of Pain Medicine, Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil GmbH Bochum, Ruhr University Bochum, Germany Center for Pain Evaluation and Treatment, University Neurological Hospital, Lyon, France Imperial College London, UK Chelsea and Westminster Hospital London, UK Department of Palliative Medicine, Rheinische Friedrich-Wilhelms University, Bonn, Germany Department of Neurology, MC Mutual, Barcelona, Spain Neuroscience Technologies, Barcelona, Spain Neuroscience Technologies, London, UK Department of Neurology, Technische Universität München, Munich, Germany Chair of Neurophysiology, Center for Biomedicine and Medical Technology Mannheim, Heidelberg University, Heidelberg, Germany Department of Neuroscience and Rehabilitation, S. Anna University Hospital of Ferrara, Ferrara, Italy University of Minnesota, 425 Delaware St SE, MMC 295, Minneapolis, MN, USA Department of Anesthesiology, University of California-San Diego, La Jolla, CA, USA Department of Family Medicine and Department of Anesthesia, McGill University, Montreal, Quebec, Canada Department of Neurology, Rambam Health Care Campus, Haifa, Israel Institute for Clinical Diabetology, German Diabetes Center at Heinrich Heine University, Leibniz Center for Diabetes Research and Department of Metabolic Diseases, University Hospital, Düsseldorf, Germany.
Nadine Attal
Ralf Baron
Didier Bouhassira
Mark Drangholt
Peter J Dyck
Robert R Edwards
Roy Freeman
Richard Gracely
Maija H Haanpaa
Per Hansson
Samar M Hatem
Elena K Krumova
Troels S Jensen
Christoph Maier
Gerard Mick
Andrew S Rice
Roman Rolke
Rolf-Detlef Treede
Jordi Serra
Thomas Toelle
Valeri Tugnoli
David Walk
Mark S Walalce
Mark Ware
David Yarnitsky
Dan Ziegler
Inserm · FRBeth Israel Deaconess Medical Center · USBG University Hospital Bergmannsheil Bochum · DECentre Hospitalier Universitaire Brugmann · BEDanish Pain Research Center · DKHarvard University · USHeinrich Heine University Düsseldorf · DEHelsinki University Hospital · FIHôpital Ambroise-Paré · FRImperial College London · GBKarolinska Institutet · SEMayo Clinic · USMcGill University · CARambam Health Care Campus · ILRuhr University Bochum · DETechnical University of Munich · DEUniversity Medical Centre Mannheim · DEUniversity of Bonn · DEUniversity of California, San Diego · USUniversity of Ferrara · IT

Funding

Biobehavioral Risk Factors for Persistent Pain following Total Knee ArthroplastyR01AG034982 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI EDWARDS, ROBERT R · 2010 to 2014
$3.2M
NIA NIH HHS R01 AG034982
6 · The paper itself

Abstract

Quantitative sensory testing (QST) is a psychophysical method used to quantify somatosensory function in response to controlled stimuli in healthy subjects and patients. Although QST shares similarities with the quantitative assessment of hearing or vision, which is extensively used in clinical practice and research, it has not gained a large acceptance among clinicians for many reasons, and in significant part because of the lack of information about standards for performing QST, its potential utility, and interpretation of results. A consensus meeting was convened by the Neuropathic Pain Special Interest Group of the International Association for the Study of Pain (NeuPSIG) to formulate recommendations for conducting QST in clinical practice and research. Research studies have confirmed the utility of QST for the assessment and monitoring of somatosensory deficits, particularly in diabetic and small fiber neuropathies; the assessment of evoked pains (mechanical and thermal allodynia or hyperalgesia); and the diagnosis of sensory neuropathies. Promising applications include the assessment of evoked pains in large-scale clinical trials and the study of conditioned pain modulation. In clinical practice, we recommend the use QST for screening for small and large fiber neuropathies; monitoring of somatosensory deficits; and monitoring of evoked pains, allodynia, and hyperalgesia. QST is not recommended as a stand-alone test for the diagnosis of neuropathic pain. For the conduct of QST in healthy subjects and in patients, we recommend use of predefined standardized stimuli and instructions, validated algorithms of testing, and reference values corrected for anatomical site, age, and gender. Interpretation of results should always take into account the clinical context, and patients with language and cognitive difficulties, anxiety, or litigation should not be considered eligible for QST. When appropriate standards, as discussed here, are applied, QST can provide important and unique information about the functional status of somatosensory system, which would be complementary to already existing clinical methods.

Indexed as

ConsensusDiagnostic Techniques, NeurologicalSensationHumansHyperalgesiaNervous System DiseasesPain MeasurementPain ThresholdPhysical StimulationPsychophysicsReference ValuesSomatoform DisordersChronic painNeuropathic painQuantitative sensory testingRecommendationsSensory neuropathies

Identifiers

PMID23742795
OpenAlexW1977612793

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.